Infinitopes
Entity

  • Infinitopes

    Created in 2021


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    2,288

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Old Road Campus Research Build, Roosevelt Dr, Headington, Oxford OX3 7FZ, UK

    Oxford

    United Kingdom

  • Employees

    Scale: 11-50

    Estimated: 30

  • Engaged catalyst

    4
    0 0

  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    Preventing deaths from cancer metastases

    Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.

Catalyst interactions
Catalyst TypeTweets Articles
Oxford Science Enterprises
Oxford Science Enterprises
Startup accelerator & VC, Venture Capital and Private Equity Principals
Oxford Science Enterprises
Startup accelerator & VC, Venture Capital and Private Equity Principals 		Other

8 Feb 2025


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing 		Other

8 Feb 2025


KPMG
KPMG
Consulting, audit, Accounting
KPMG
Consulting, audit, Accounting 		Other

31 Jul 2024


UK Atomic Energy Authority
UK Atomic Energy Authority
Research, National and local authorities
UK Atomic Energy Authority
Research, National and local authorities 		Other

30 Apr 2024


Social network dynamics
Similar entities
BETA
Last news
Show all articles